SynthesisPloS one2011
Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis.
Synthesis in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 4 syntheses or guidelines pooled it, 144 citations in OpenAlex.
- Association between tea consumption and prevention of coronary artery disease: A systematic review and dose-response meta-analysis.Frontiers in nutrition · 2022Pooled it
- Tea intake and cardiovascular disease: an umbrella review.Annals of medicine · 2021Pooled it
- The effect of black tea on blood pressure: a systematic review with meta-analysis of randomized controlled trials.PloS one · 2014Pooled it
- Tea consumption and risk of stroke: a dose-response meta-analysis of prospective studies.Journal of Zhejiang University. Science. B · 2012Pooled it
- The Acute Ingestion of Yerba Mate (Ilex paraguariensis) Infusion Does Not Modify Endothelial Function, Hemodynamics, or Heart Rate Variability: A Randomized Crossover Clinical Trial.Plant foods for human nutrition (Dordrecht, Netherlands) · 2024Trial
- Trial
- Two apples a day lower serum cholesterol and improve cardiometabolic biomarkers in mildly hypercholesterolemic adults: a randomized, controlled, crossover trial.The American journal of clinical nutrition · 2020Trial
- Tea-induced improvement of endothelial function in humans: No role for epigallocatechin gallate (EGCG).Scientific reports · 2017Trial
- Supplementation with a Polyphenol-Rich Extract, PerfLoadNutrients · 2017Trial
- A green tea-containing starch confection increases plasma catechins without protecting against postprandial impairments in vascular function in normoglycemic adults.Food & function · 2016Trial
- The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: A double-blind randomised clinical trial.Scientific reports · 2016Trial
- Consumption of a polyphenol-rich grape-wine extract lowers ambulatory blood pressure in mildly hypertensive subjects.Nutrients · 2015Trial
- Trial
- Associations of proanthocyanidin intake with renal function and clinical outcomes in elderly women.PloS one · 2013Trial
- Comprehensive Analysis of Brewed Tea: Boron Content, Total Antioxidant and Oxidant Capacity, Oxidative Stress, and pH value.Biological trace element research · 2026Article
- Tea consumption and cardiovascular risk and outcomes: mechanistic insights, epidemiological evidence, and clinical implications.Frontiers in cardiovascular medicine · 2026Review
- Green Tea Mitigates the Hallmarks of Aging and Age-Related Multisystem Deterioration.Aging and disease · 2025Review
- Natural Products to Promote Vascular Health.Handbook of experimental pharmacology · 2025Review
- From a Cup of Tea to Cardiovascular Care: Vascular Mechanisms of Action.Life (Basel, Switzerland) · 2024Review
- Exploring FourMolecules (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTea consumption is associated with a lower risk of cardiovascular disease including stroke. Direct effects of tea components on the vasculature, particularly the endothelium, may partly explain this association.
objectiveWe performed a meta-analysis of controlled human intervention studies on the effect of tea on flow-mediated dilation (FMD) of the brachial artery, a measurement of endothelial function, which is suggested to be associated with cardiovascular risk.
methodsHuman intervention studies were identified by systematic search of the databases Medline, Embase, Chemical Abstracts and Biosis through March 2009 and by hand-searching related articles. Studies were selected based on predefined criteria: intervention with tea as the sole experimental variable, placebo-controlled design, and no missing data on FMD outcome or its variability. A random effects model was used to calculate the pooled overall effect on FMD due to the intake of tea. The impact of various subject and treatment characteristics was investigated in the presence of heterogeneity.
resultsIn total, 9 studies from different research groups were included with 15 relevant study arms. The overall absolute increase in FMD of tea vs. placebo was 2.6% of the arterial diameter (95% CI: 1.8-3.3%; P-value <0.001) for a median daily dose of 500 mL of tea (2-3 cups). This is a relative increase of approximately 40% compared to the average FMD of 6.3% measured under placebo or baseline conditions. There was significant heterogeneity between studies (P-value <0.001) that might partly be explained by the cuff position either distal or proximal to the area of FMD measurement. No indication for publication bias was found.
conclusionModerate consumption of tea substantially enhances endothelial-dependent vasodilation. This may provide a mechanistic explanation for the reduced risk of cardiovascular events and stroke observed among tea drinkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.